Heart failure, referred to as heart failure, is a complex group of clinical symptoms caused by abnormal changes in cardiac structure and (or) function due to various reasons, resulting in ventricular systolic and (or) diastolic dysfunction. Syndrome, mainly manifested as dyspnea, fatigue and fluid retention (pulmonary congestion, systemic congestion and peripheral edema). The TCM syndrome types of heart failure can be summarized as 3 basic syndrome types: qi deficiency and blood stasis, qi and yin deficiency and blood stasis, and yang qi deficiency and blood stasis. The consensus of experts on the diagnosis and treatment of chronic heart failure in traditional Chinese medicine points out that for patients with qi and yin deficiency and blood stasis, Buyiqiangxin tablets or Shengmai capsules can be used.
Ben Yi Qiangxin Tablets
Ben Yi Qiang Xin Tablets, made of ginseng, astragalus, incense It is composed of Jiapi, Salvia miltiorrhiza, Ophiopogon japonicus and Tinglizi. It has the effect of nourishing qi, nourishing yin, promoting blood circulation and diuresis. For chronic congestive heart failure caused by coronary heart disease and hypertensive heart disease (heart function classification II-III), Chinese medicine syndrome differentiation belongs to qi and yin deficiency and blood stasis and water stop syndrome. Symptoms include palpitations, shortness of breath, fatigue, chest tightness, chest pain, pale complexion, sweating, dry mouth, edema, and bruised lips.
Buyi Qiangxin Tablet is a clinical prescription of Professor Yu Zuoying of Jilin Provincial Institute of Traditional Chinese Medicine for many years. Raising yang, diuresis and swelling; Ophiopogon japonicus nourishes yin and moistens the lungs, benefits the stomach and generates fluid, clears the heart and eliminates vexation; astragalus tonifies qi, and ginseng can enter the yin points, so ginseng and Ophiopogon japonicus are combined to nourish yin and promote fluid, and the three medicines are combined to achieve qi and yin. The purpose of double complement. Danshen enters the blood to activate the blood and cool the blood, so as to clear the blood vessels; Tinglizi purifies the lungs, relieves asthma, and diureses water to reduce swelling; Xiangjiapi dispels rheumatism, strengthens muscles and bones, and diureses. Throughout the whole prescription, it is beneficial to nourish qi and nourish yin, promote blood circulation and diuretic water, and aims at the pathogenesis of heart failure caused by deficiency of both qi and yin and blood stasis and water stasis.
Modern pharmacological studies have shown that plasma angiotensin II and aldosterone levels in patients with chronic heart failure decreased after treatment with Buyiqiangxin Tablet, suggesting that Buyiqiangxin Tablet has an effect on renin-angiotensin -The excitation of the aldosterone system has a down-regulating effect, which is beneficial to block myocardial remodeling and delay the progressive deterioration of heart failure. Buyiqiangxin Tablets can also reduce the levels of cytokines such as N-terminal atrial linatide (BNP), which is beneficial to relieve the symptoms of heart failure and the regulation of the renin-angiotensin-aldosterone system, and promote the improvement of cardiac function in patients with chronic heart failure.
Clinical studies have shown that Buyiqiangxin Tablet has an exact curative effect on patients with chronic heart failure. Ventricular contraction, improve cardiac function and ejection fraction, and improve the patient’s own quality of life. In addition, studies have shown that Buyiqiangxin Tablets can inhibit the loss of ions caused by diuresis in the human body, can effectively avoid the lack of electrolytes in the body, etc., can inhibit the abnormal proliferation of pulmonary blood vessels, reduce pulmonary artery pressure, reduce the patient’s ventricular load, and relieve fatigue. Symptoms, enhance their own skeletal muscle exercise capacity. After treatment, the patient’s quality of life and left ventricular ejection fraction increased.
Shengmai Capsule
Shengmai Capsule is composed of red ginseng, Ophiopogon japonicus and Schisandra chinensis. It has the effects of nourishing qi, nourishing yin and producing fluid. Used for deficiency of both qi and yin, palpitations, shortness of breath, spontaneous perspiration, etc. It is clinically used for coronary heart disease, heart failure and other diseases with the above syndromes.
In this prescription, ginseng nourishes the five internal organs, clears the blood vessels, and calms the spirit. It is an essential medicine for tonifying vitality. The so-called qi is the commander of blood, and the movement of qi is the movement of blood, supplementing vitality. It can promote the whole body blood circulation. And ginseng can increase cardiac output, reduce myocardial oxygen consumption, and improve myocardial blood supply. Its active ingredient, ginsenosides, can scavenge oxygen free radicals, protect endothelial cells, and resist atherosclerotic lesions.
Ophiopogon japonicus nourishes yin and eliminates vexation, returns to the heart, lung and stomach meridians, can nourish the yin of the heart, clear the heart heat, remove vexation and soothe the nerves. Effectively exert anti-myocardial ischemia function and enhance myocardial diastolic and systolic function. The main components of Schisandra chinensis, polysaccharides and lignin, can effectively exert cardiovascular protection by fighting against oxygen free radicals.
Three herbs, one tonic, one moisturizing and one astringent, have the functions of nourishing qi and restoring pulse, nourishing yin and invigorating body fluid. They can enhance myocardial relaxation and contraction, improve myocardial oxygen supply and blood supply, and improve myocardial energy metabolism. Thereby improving the efficiency of clinical treatment. Studies have shown that Shengmai Capsule can reduce the inflammatory damage of the body in patients with ischemic cardiomyopathy, and has various effects such as enhancing myocardial contractility, reducing vascular resistance, resisting myocardial ischemia and improving heart failure.
Clinical studies have shown that Shengmai Capsules has definite clinical efficacy in the treatment of chronic congestive heart failure, and it can significantly improve the cardiac systolic and diastolic functions, ventricular remodeling, and valve status of patients. , pulmonary artery pressure, etc., is conducive to improving the patient’s hemodynamic status and overall cardiac function. On the basis of standard treatment of western medicine, the addition of Shengmai Capsules in the treatment of elderly chronic heart failure can significantly improve clinical treatment.It can improve the quality of life and cardiac function of patients, regulate the level of serum inflammatory factors, and inhibit myocardial fibrosis.